BAKER BROS. ADVISORS LP Transaction History

Date Transaction Value Shares Traded Form
Dec 14 2023
SELL
Sale (or disposition) back to the issuer
$10,238,247,187 $229.0 p/Share
44,708,503
May 31 2023
BUY
Grant, award, or other acquisition
-
4,088
May 01 2023
SELL
Other acquisition or disposition
-
2,368,357
May 01 2023
BUY
Exercise of conversion of derivative security
$642,250 $36.7 p/Share
17,500
May 13 2022
BUY
Grant, award, or other acquisition
-
3,006
Mar 08 2022
BUY
Exercise of conversion of derivative security
$702,100 $20.06 p/Share
35,000
Dec 01 2021
SELL
Open market or private sale
$15,062,431 $161.18 p/Share
93,451
Nov 30 2021
SELL
Open market or private sale
$48,897,233 $162.21 p/Share
301,444
May 14 2021
BUY
Grant, award, or other acquisition
-
2,804
May 14 2021
BUY
Exercise of conversion of derivative security
$665,700 $19.02 p/Share
35,000
May 15 2020
SELL
Open market or private sale
$280,000,000 $160.0 p/Share
1,750,000
May 15 2020
BUY
Grant, award, or other acquisition
-
2,670
May 08 2020
SELL
Open market or private sale
$79,250,000 $158.5 p/Share
500,000
May 07 2020
SELL
Open market or private sale
$27,706,421 $164.68 p/Share
168,244
May 06 2020
SELL
Open market or private sale
$64,455,499 $165.24 p/Share
390,072
Apr 23 2020
BUY
Exercise of conversion of derivative security
$446,600 $12.76 p/Share
35,000
Jun 06 2019
SELL
Other acquisition or disposition
-
1,002,483
May 20 2019
BUY
Grant, award, or other acquisition
-
5,926
Apr 29 2019
BUY
Exercise of conversion of derivative security
$167,600 $8.38 p/Share
20,000
May 18 2018
BUY
Grant, award, or other acquisition
$420,098 $56.77 p/Share
7,400
May 08 2018
BUY
Open market or private purchase
$6,828,074 $54.02 p/Share
126,399
May 07 2018
BUY
Open market or private purchase
$6,965,696 $53.7 p/Share
129,715
May 04 2018
BUY
Open market or private purchase
$10,775,009 $52.68 p/Share
204,537
May 02 2018
BUY
Open market or private purchase
$3,687,606 $52.72 p/Share
69,947
May 01 2018
BUY
Exercise of conversion of derivative security
$201,600 $10.08 p/Share
20,000

Also insider at

INCY
INCYTE CORP Healthcare
GHDX
GENOMIC HEALTH INC
IDRA
IDERA PHARMACEUTICALS, INC. Healthcare
RYTM
RHYTHM PHARMACEUTICALS, INC. Healthcare
BGNE
BeiGene, Ltd. Healthcare
ACAD
ACADIA PHARMACEUTICALS INC Healthcare
MRTX
Mirati Therapeutics, Inc. Healthcare
BLCM
BELLICUM PHARMACEUTICALS, INC Healthcare
NVTA
Invitae Corp Healthcare
ALXN
ALEXION PHARMACEUTICALS, INC.
NLTX
Neoleukin Therapeutics, Inc. Healthcare
KNSA
Kiniksa Pharmaceuticals, Ltd. Healthcare
KOD
Kodiak Sciences Inc. Healthcare
HOOK
HOOKIPA Pharma Inc. Healthcare
BCEL
Atreca, Inc. Healthcare
IGMS
IGM Biosciences, Inc. Healthcare
ZYME
Zymeworks Inc. Healthcare
PRLD
Prelude Therapeutics Inc Healthcare
TLIS
Talis Biomedical Corp Healthcare
AGLE
Aeglea BioTherapeutics, Inc. Healthcare
TCRX
TScan Therapeutics, Inc. Healthcare
TRDA
Entrada Therapeutics, Inc. Healthcare
DBVT
DBV Technologies S.A. Healthcare
MDGL
MADRIGAL PHARMACEUTICALS, INC. Healthcare
VTVT
vTv Therapeutics Inc. Healthcare
KYMR
Kymera Therapeutics, Inc. Healthcare
BCYC
BICYCLE THERAPEUTICS plc Healthcare
IMCR
Immunocore Holdings plc Healthcare
BBA

Baker Bros. Advisors LP

Director
New York, NY

Track Institutional and Insider Activities on SGEN

Follow Seagen Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SGEN shares.

Notify only if

Insider Trading

Get notified when an Seagen Inc. insider buys or sells SGEN shares.

Notify only if

News

Receive news related to Seagen Inc.

Track Activities on SGEN